Literature DB >> 21849623

Immunochemical detection of cytochrome P450 enzymes in liver microsomes of 27 cynomolgus monkeys.

Shotaro Uehara1, Norie Murayama, Yasuharu Nakanishi, Darryl C Zeldin, Hiroshi Yamazaki, Yasuhiro Uno.   

Abstract

The cynomolgus monkey is widely used as a primate model in preclinical studies because of its evolutionary closeness to humans. Despite their importance in drug metabolism, the content of each cytochrome P450 (P450) enzyme has not been systematically determined in cynomolgus monkey livers. In this study, liver microsomes of 27 cynomolgus monkeys were analyzed by immunoblotting using selective P450 antibodies. The specificity of each antibody was confirmed by analyzing the cross-reactivity against 19 CYP1-3 subfamily enzymes using recombinant proteins. CYP2A, CYP2B6, CYP2C9/19, CYP2C76, CYP2D, CYP2E, CYP3A4, and CYP3A5 were detected in all 27 animals. In contrast, CYP1A, CYP1D, and CYP2J were below detectable levels in all liver samples. The average content of each P450 showed that among the P450s analyzed CYP3A (3A4 and 3A5) was the most abundant (40% of total immunoquantified P450), followed by CYP2A (25%), CYP2C (14%), CYP2B6 (13%), CYP2E1 (11%), and CYP2D (3%). No apparent sex differences were found for any P450. Interanimal variations ranged from 2.6-fold (CYP3A) to 11-fold (CYP2C9/19), and most P450s (CYP2A, CYP2D, CYP2E, CYP3A4, and CYP3A5) varied 3- to 4-fold. To examine the correlations of P450 content with enzyme activities, metabolic assays were performed in 27 cynomolgus monkey livers using 7-ethoxyresorufin, coumarin, pentoxyresorufin, flurbiprofen, bufuralol, dextromethorphan, and midazolam. CYP2D and CYP3A4 contents were significantly correlated with typical reactions of human CYP2D (bufuralol 1'-hydroxylation and dextromethorphan O-deethylation) and CYP3A (midazolam 1'-hydroxylation and 4-hydroxylation). The results presented in this study provide useful information for drug metabolism studies using cynomolgus monkeys.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21849623      PMCID: PMC3199985          DOI: 10.1124/jpet.111.185009

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  47 in total

1.  A novel cytochrome P450 enzyme responsible for the metabolism of ebastine in monkey small intestine.

Authors:  T Hashizume; M Mise; S Matsumoto; Y Terauchi; T Fujii; S Imaoka; Y Funae; T Kamataki; H Miyazaki
Journal:  Drug Metab Dispos       Date:  2001-06       Impact factor: 3.922

2.  Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).

Authors:  S A Wrighton; W R Brian; M A Sari; M Iwasaki; F P Guengerich; J L Raucy; D T Molowa; M Vandenbranden
Journal:  Mol Pharmacol       Date:  1990-08       Impact factor: 4.436

3.  Cloning of CYP2J2 gene and identification of functional polymorphisms.

Authors:  Lorraine M King; Jixiang Ma; Supawon Srettabunjong; Joan Graves; J Alyce Bradbury; Leping Li; Martin Spiecker; James K Liao; Harvey Mohrenweiser; Darryl C Zeldin
Journal:  Mol Pharmacol       Date:  2002-04       Impact factor: 4.436

4.  Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

Authors:  T Shimada; H Yamazaki; M Mimura; Y Inui; F P Guengerich
Journal:  J Pharmacol Exp Ther       Date:  1994-07       Impact factor: 4.030

5.  Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human.

Authors:  R J Edwards; B P Murray; S Murray; T Schulz; D Neubert; T W Gant; S S Thorgeirsson; A R Boobis; D S Davies
Journal:  Carcinogenesis       Date:  1994-05       Impact factor: 4.944

6.  Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).

Authors:  N Sadrieh; E G Snyderwine
Journal:  Carcinogenesis       Date:  1995-07       Impact factor: 4.944

7.  Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.

Authors:  P Bullock; R Pearce; A Draper; J Podval; W Bracken; J Veltman; P Thomas; A Parkinson
Journal:  Drug Metab Dispos       Date:  1995-07       Impact factor: 3.922

Review 8.  Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants.

Authors:  David R Nelson; Darryl C Zeldin; Susan M G Hoffman; Lois J Maltais; Hester M Wain; Daniel W Nebert
Journal:  Pharmacogenetics       Date:  2004-01

9.  Comparison of human and rhesus monkey in vitro phase I and phase II hepatic drug metabolism activities.

Authors:  J C Stevens; L A Shipley; J R Cashman; M Vandenbranden; S A Wrighton
Journal:  Drug Metab Dispos       Date:  1993 Sep-Oct       Impact factor: 3.922

10.  Characterization of cytochrome P-450 2B6 in human liver microsomes.

Authors:  M Mimura; T Baba; H Yamazaki; S Ohmori; Y Inui; F J Gonzalez; F P Guengerich; T Shimada
Journal:  Drug Metab Dispos       Date:  1993 Nov-Dec       Impact factor: 3.922

View more
  4 in total

1.  Immunochemical quantification of cynomolgus CYP2J2, CYP4A and CYP4F enzymes in liver and small intestine.

Authors:  Shotaro Uehara; Norie Murayama; Yasuharu Nakanishi; Chika Nakamura; Takanori Hashizume; Darryl C Zeldin; Hiroshi Yamazaki; Yasuhiro Uno
Journal:  Xenobiotica       Date:  2014-08-20       Impact factor: 1.908

2.  Immunochemical detection of cytochrome P450 enzymes in small intestine microsomes of male and female untreated juvenile cynomolgus monkeys.

Authors:  Shotaro Uehara; Norie Murayama; Yasuharu Nakanishi; Chika Nakamura; Takanori Hashizume; Darryl C Zeldin; Hiroshi Yamazaki; Yasuhiro Uno
Journal:  Xenobiotica       Date:  2014-03-05       Impact factor: 1.908

3.  Qualitative de novo analysis of full length cDNA and quantitative analysis of gene expression for common marmoset (Callithrix jacchus) transcriptomes using parallel long-read technology and short-read sequencing.

Authors:  Makiko Shimizu; Shunsuke Iwano; Yasuhiro Uno; Shotaro Uehara; Takashi Inoue; Norie Murayama; Jun Onodera; Erika Sasaki; Hiroshi Yamazaki
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

4.  Species Differences in Microsomal Metabolism of Xanthine-Derived A1 Adenosine Receptor Ligands.

Authors:  Daniela Schneider; Dirk Bier; Marcus Holschbach; Andreas Bauer; Bernd Neumaier
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.